[PDF] Top 20 Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma

... mal tissue tolerance dose. Using either cone-down for 3D-CRT or SIB technique for IMRT, the total dose of radiation was ap- proximately 54 ...if patients had an- other healthy kidney or if kidney was ... See full document

... 222 patients with a diagnosis of recurrent RPS detected by biopsy or CT scanning and magnetic resonance imaging (MRI) were treated comprehensively after surgical resection at our ...institution. Patients ... See full document

... conformal radiotherapy (3D-CRT) to IMRT and image-guided radiotherapy ...experience using IMRT for NeoRT to treat ...posterior retroperitoneal surgical margin at high risk for ...83 ... See full document

... potential benefits to some extent. Although the included enti- ties cannot be compared with STSs, for which irradiation is limited due to the large tumor size and critical anatomic sites such as major vessels and nerves ... See full document

... of postoperative complications and ...huge retroperitoneal sarcoma for which wide excision and left colectomy with colo-colic anastomosis was ... See full document

... of sarcoma trials incorporating novel cytotoxics and targeted ...STS patients this ...STS patients currently in phase III testing (Table ...for sarcoma therapy, with new targets and drugs ... See full document

... synovial sarcoma the most common subtype to receive doublet chemotherapy with doxorubicin and ifosfamide (n = 5, 38 ...Fourteen patients (16 %) were enrolled in clinical trials for the first-line ...of ... See full document

... 843 patients, were eligible for analysis. We included 424 patients (three studies) who received pazopanib 800 mg daily, 353 patients (five studies) who received sorafenib 400 mg twice daily and 66 ... See full document

... Following the surgery, edema was clinically evident in about 40% of the treated cases, no difference has been observed between the two different treatments respectively veins treated with grafting or with ligation as ... See full document

... subcutaneous tissue, and lymph nodes. Additionally, many sarcoma patients presenting initially with localized disease may relapse at metastatic ...of patients with metastatic ...Ewing ... See full document

... In addition to QoL, we aimed to provide a more precise picture of the possible dysfunctions patients experienced after TM-ILP treatment and complete tumor resection. Because TM-ILP was used for the treatment of ... See full document

... 632 patients with grade II EPNs treated by cancer-directed surgery with or without PORT were obtained from the SEER ...in patients who underwent ...analysis using SEER data indicates survival ... See full document

... Pleomorphic liposarcoma (PLPS) is the less common subtype of liposarcoma, accounting for only 5%–15% of all liposarcomas and characterized by a high malignant potential with metastases in 30-35% of cases. PLPS affects ... See full document

... 7 patients with old elbow fracture-dislocation with at least one month’s delay in ...their patients had fractures interfering with elbow ...5 patients with old elbow dislocation without associated ... See full document

... an efficacy standpoint and 2) monitoring patients for cardio- toxicity after sufficient drug dosing and follow-up periods to allow meaningful comparison with data for DOX and other ... See full document

... Another unanswered question is the reason behind the disparity between PFS and OS study end points. Some interesting hypotheses could explain this topic, such as olaratumab may display a long-term modulatory effect on ... See full document

... of patients treated but found a number of laboratory markers to predict for ...of patients with advanced STC were lymphopenic and this was associated with worse survival ...in patients with advanced ... See full document

... (MDS) patients compared to other standard therapies ...potential efficacy of epigenetic ther- apy in STS is supported by preclinical studies employing HDAC inhibitors ...Ewing’s sarcoma cells, HDAC ... See full document

... of patients received more than two lines of systemic ...in patients receiving pazopanib in the third- or fourth-line settings versus the first- or second- line ...or patients who were not eligible to ... See full document

... adult patients with advanced STS who have not responded to treatment with doxorubicin and ...in patients with non-progressive disease is not ...the efficacy and safety of combination therapy of ... See full document